Latest News about KYMR
Recent news which mentions KYMR
Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary
September 15, 2022
From Benzinga
Kymera Gets Orphan Drug Status For Rare Blood Cancer Candidate
September 15, 2022
Tickers
KYMR
From Benzinga
Looking Into Kymera Therapeutics's Return On Capital Employed
September 02, 2022
Tickers
KYMR
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2022
August 15, 2022
From Benzinga
During the second quarter, Kymera Therapeutics (KYMR) reported an 8-cent decline in earnings per share
August 12, 2022
Tickers
KYMR
From Best Stocks
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2022
August 03, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
3 Biotech Stocks to Buy Before They Boom
June 01, 2022
From InvestorPlace
Executives Buy Around $141M Of 4 Stocks
May 10, 2022
From Benzinga
81 Biggest Movers From Yesterday
May 05, 2022
From Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
May 04, 2022
From Benzinga
80 Biggest Movers From Yesterday
May 04, 2022
From Benzinga
Mid-Afternoon Market Update: Kymera Therapeutics Drops After Q1 Results; Belite Bio Shares Spike Higher
May 03, 2022
From Benzinga
Why Kymera Therapeutics Shares Are Falling Today
May 03, 2022
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
41 Stocks Moving In Tuesday's Mid-Day Session
May 03, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.